Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Demographic characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant infections in Indian population

View through CrossRef
Abstract Importance Higher risks of contracting infection, developing severe illness and mortality are known facts in aged and male sex if exposed to the wild type SARS-CoV-2 strains (Wuhan and B.1 strains). Now, accumulating evidence suggests greater involvement of lower age and narrowing the age and sex based differences for the severity of symptoms in infections with emerging SARS-CoV-2 variants. Delta variant (B.1.617.2) is now a globally dominant SARS-CoV-2 strain, however, current evidence on demographic characteristics for this variant are limited. Recently, delta variant caused a devastating second wave of COVID-19 in India. We performed a demographic characterization of COVID-19 cases in Indian population diagnosed with SARS-CoV-2 genomic sequencing for delta variant. Objective To determine demographic characteristics of delta variant in terms of age and sex, severity of the illness and mortality rate, and post-vaccination infections. Design A cross sectional study Setting Demographic characteristics, including vaccination status (for two complete doses) and severity of the illness and mortality rate, of COVID-19 cases caused by wild type strain (B.1) and delta variant (B.1.617.2) of SARS-CoV-2 in Indian population were studied. Participants COVID-19 cases for which SARS-CoV-2 genomic sequencing was performed and complete demographic details (age, sex, and location) were available, were included. Exposures SARS-CoV-2 infection with Delta (B.1.617.2) variant and wild type (B.1) strain. Main Outcomes and Measures The patient metadata containing details for demographic and vaccination status (two complete doses) of the COVID-19 patients with confirmed delta variant and WT (B.1) infections were analyzed [total number of cases (N) =9500, N delta =6238, N WT =3262]. Further, severity of the illness and mortality were assessed in subsets of patients. Final data were tabulated and statistically analyzed to determine age and sex based differences in chances of getting infection and the severity of illness, and post-vaccination infections were compared between wild type and delta variant strains. Graphs were plotted to visualize the trends. Results With delta variant, in comparison to wild type (B.1) strain, higher proportion of lower age groups, particularly <20 year (0-9 year: 4.47% vs. 2.3%, 10-19 year: 9% vs. 7%) were affected. The proportion of women contracting infection were increased (41% vs. 36%). The higher proportion of total young (0-19 year, 10% vs. 4%) (p=.017) population and young (14% vs. 3%) as well as adult (20-59 year, 75% vs. 55%) women developed symptoms/hospitalized with delta variant in comparison to B.1 infection (p< .00001). The mean age of contracting infection [Delta, men=37.9 (±17.2) year, women=36.6 (±17.6) year; B.1, men=39.6 (±16.9) year and women= 40.1 (±17.4) year (p< .001)] as well as developing symptoms/hospitalization [Delta, men=39.6(± 17.4) year, women=35.6 (±16.9) year; B.1, men=47(±18) year and women= 49.5(±20.9) year (p< .001)] was considerably lower. The total mortality was about 1.8 times higher (13% vs. 7%). Risk of death increased irrespective of the sex (Odds ratio: 3.034, 95% Confidence Interval: 1.7-5.2, p<0.001), however, increased proportion of women (32% vs. 25%) were died. Further, multiple incidences of delta infections were noted following complete vaccination. Conclusions and Relevance The increased involvement of young (0-19 year) and women, lower mean age for contracting infection and symptomatic illness/hospitalization, higher mortality, and frequent incidences of post-vaccination infections with delta variant compared to wild type strain raises significant epidemiological concerns. Key Points Question Did SARS-CoV-2 B.1.617.2 (Delta) variant infections show varied demographic characteristics in comparison to wild type strains? Findings In this cross sectional study viral genomic sequences of 9500 COVID-19 patients were analyzed. As the key findings, increased involvement of young (0-19 year) and women, lower mean age for contracting infection and symptomatic illness/hospitalization, higher mortality, and frequent incidences of post-vaccination infections with delta variant in comparison to wild type (WT) strain (B.1) were observed. Meaning The findings of this study suggest that delta variant has varied demographic characteristics reflecting increased involvement of the young and women, and increased lethality in comparison to wild type strains.
Title: Demographic characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant infections in Indian population
Description:
Abstract Importance Higher risks of contracting infection, developing severe illness and mortality are known facts in aged and male sex if exposed to the wild type SARS-CoV-2 strains (Wuhan and B.
1 strains).
Now, accumulating evidence suggests greater involvement of lower age and narrowing the age and sex based differences for the severity of symptoms in infections with emerging SARS-CoV-2 variants.
Delta variant (B.
1.
617.
2) is now a globally dominant SARS-CoV-2 strain, however, current evidence on demographic characteristics for this variant are limited.
Recently, delta variant caused a devastating second wave of COVID-19 in India.
We performed a demographic characterization of COVID-19 cases in Indian population diagnosed with SARS-CoV-2 genomic sequencing for delta variant.
Objective To determine demographic characteristics of delta variant in terms of age and sex, severity of the illness and mortality rate, and post-vaccination infections.
Design A cross sectional study Setting Demographic characteristics, including vaccination status (for two complete doses) and severity of the illness and mortality rate, of COVID-19 cases caused by wild type strain (B.
1) and delta variant (B.
1.
617.
2) of SARS-CoV-2 in Indian population were studied.
Participants COVID-19 cases for which SARS-CoV-2 genomic sequencing was performed and complete demographic details (age, sex, and location) were available, were included.
Exposures SARS-CoV-2 infection with Delta (B.
1.
617.
2) variant and wild type (B.
1) strain.
Main Outcomes and Measures The patient metadata containing details for demographic and vaccination status (two complete doses) of the COVID-19 patients with confirmed delta variant and WT (B.
1) infections were analyzed [total number of cases (N) =9500, N delta =6238, N WT =3262].
Further, severity of the illness and mortality were assessed in subsets of patients.
Final data were tabulated and statistically analyzed to determine age and sex based differences in chances of getting infection and the severity of illness, and post-vaccination infections were compared between wild type and delta variant strains.
Graphs were plotted to visualize the trends.
Results With delta variant, in comparison to wild type (B.
1) strain, higher proportion of lower age groups, particularly <20 year (0-9 year: 4.
47% vs.
2.
3%, 10-19 year: 9% vs.
7%) were affected.
The proportion of women contracting infection were increased (41% vs.
36%).
The higher proportion of total young (0-19 year, 10% vs.
4%) (p=.
017) population and young (14% vs.
3%) as well as adult (20-59 year, 75% vs.
55%) women developed symptoms/hospitalized with delta variant in comparison to B.
1 infection (p< .
00001).
The mean age of contracting infection [Delta, men=37.
9 (±17.
2) year, women=36.
6 (±17.
6) year; B.
1, men=39.
6 (±16.
9) year and women= 40.
1 (±17.
4) year (p< .
001)] as well as developing symptoms/hospitalization [Delta, men=39.
6(± 17.
4) year, women=35.
6 (±16.
9) year; B.
1, men=47(±18) year and women= 49.
5(±20.
9) year (p< .
001)] was considerably lower.
The total mortality was about 1.
8 times higher (13% vs.
7%).
Risk of death increased irrespective of the sex (Odds ratio: 3.
034, 95% Confidence Interval: 1.
7-5.
2, p<0.
001), however, increased proportion of women (32% vs.
25%) were died.
Further, multiple incidences of delta infections were noted following complete vaccination.
Conclusions and Relevance The increased involvement of young (0-19 year) and women, lower mean age for contracting infection and symptomatic illness/hospitalization, higher mortality, and frequent incidences of post-vaccination infections with delta variant compared to wild type strain raises significant epidemiological concerns.
Key Points Question Did SARS-CoV-2 B.
1.
617.
2 (Delta) variant infections show varied demographic characteristics in comparison to wild type strains? Findings In this cross sectional study viral genomic sequences of 9500 COVID-19 patients were analyzed.
As the key findings, increased involvement of young (0-19 year) and women, lower mean age for contracting infection and symptomatic illness/hospitalization, higher mortality, and frequent incidences of post-vaccination infections with delta variant in comparison to wild type (WT) strain (B.
1) were observed.
Meaning The findings of this study suggest that delta variant has varied demographic characteristics reflecting increased involvement of the young and women, and increased lethality in comparison to wild type strains.

Related Results

The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
MO152: SARS-COV-2 Infection and Kidney Impairment
MO152: SARS-COV-2 Infection and Kidney Impairment
Abstract BACKGROUND AND AIMS The objectives of the present study are to compare the renal impairment between patients with SARS-...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
Analyses of the Spike Proteins of Severe Acute Respiratory Syndrome-Related Coronaviruses
Analyses of the Spike Proteins of Severe Acute Respiratory Syndrome-Related Coronaviruses
Aim: To analyze spike proteins of Severe Acute Respiratory Syndrome (SARS)-related coronaviruses (CoVs) for their conserved motifs, Receptor-Binding  Domain (RBD), Receptor Binding...
SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion
SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously evolving, bringing great challenges to the control of the virus. In the...
Genomique surveillance of severe acute respiratry  syndrome coronavirus-2 (SARS-CoV-2) in Brazzaville, Republic of Congo
Genomique surveillance of severe acute respiratry  syndrome coronavirus-2 (SARS-CoV-2) in Brazzaville, Republic of Congo
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus 2019 (COVID-19) disease, was first detected in China [1]. Variants of SARS-CoV-2 ha...

Back to Top